BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 17515557)

  • 1. Allogeneic stem cell transplantation corrects biochemical derangements in MNGIE.
    Rahman S; Hargreaves IP
    Neurology; 2007 May; 68(21):1872; author reply 1872; discussion 1872-3. PubMed ID: 17515557
    [No Abstract]   [Full Text] [Related]  

  • 2. Mitochondrial myopathies.
    DiMauro S
    Curr Opin Rheumatol; 2006 Nov; 18(6):636-41. PubMed ID: 17053512
    [TBL] [Abstract][Full Text] [Related]  

  • 3. When should a rheumatologist suspect a mitochondrial myopathy?
    Albert DA; Cohen JA; Burns CM; Hickey WF; Prock TL; James JA; Rhodes CH; Wortmann RL
    Arthritis Care Res (Hoboken); 2011 Nov; 63(11):1497-502. PubMed ID: 22034111
    [No Abstract]   [Full Text] [Related]  

  • 4. COQ2 nephropathy: a newly described inherited mitochondriopathy with primary renal involvement.
    Diomedi-Camassei F; Di Giandomenico S; Santorelli FM; Caridi G; Piemonte F; Montini G; Ghiggeri GM; Murer L; Barisoni L; Pastore A; Muda AO; Valente ML; Bertini E; Emma F
    J Am Soc Nephrol; 2007 Oct; 18(10):2773-80. PubMed ID: 17855635
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A mutation in para-hydroxybenzoate-polyprenyl transferase (COQ2) causes primary coenzyme Q10 deficiency.
    Quinzii C; Naini A; Salviati L; Trevisson E; Navas P; Dimauro S; Hirano M
    Am J Hum Genet; 2006 Feb; 78(2):345-9. PubMed ID: 16400613
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increase of CoQ10 production level by the coexpression of decaprenyl Diphosphate synthase and 1-deoxy-D-xylulose 5-phosphate synthase isolated from Rhizobium radiobacter ATCC 4718 in recombinant Escherichia coli.
    Seo MJ; Im EM; Nam JY; Kim SO
    J Microbiol Biotechnol; 2007 Jun; 17(6):1045-8. PubMed ID: 18050926
    [No Abstract]   [Full Text] [Related]  

  • 7. [Greek, but Olympiad impossible].
    Memain N; Larroche C; Dray JM; Piette AM; Blétry O
    Rev Med Interne; 1999; 20 Suppl 2():264s-266s. PubMed ID: 10422163
    [No Abstract]   [Full Text] [Related]  

  • 8. SANDO: two novel mutations in POLG1 gene.
    Gago MF; Rosas MJ; Guimarães J; Ferreira M; Vilarinho L; Castro L; Carpenter S
    Neuromuscul Disord; 2006 Aug; 16(8):507-9. PubMed ID: 16919951
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mitochondrial neurogastrointestinal encephalomyopathy (MNGIE): biochemical features and therapeutic approaches.
    Lara MC; Valentino ML; Torres-Torronteras J; Hirano M; Martí R
    Biosci Rep; 2007 Jun; 27(1-3):151-63. PubMed ID: 17549623
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Current status of mitochondrial diseases].
    Lombès A
    Rev Neurol (Paris); 1998 Apr; 154(3):261-4. PubMed ID: 9773055
    [No Abstract]   [Full Text] [Related]  

  • 11. Non-myeloablative allogeneic hematopoietic stem cell transplants.
    Fagioli F; Ricchiardi A; Carnevale-Schianca F
    Haematologica; 2002 Aug; 87(8 Suppl):13-9. PubMed ID: 12412384
    [No Abstract]   [Full Text] [Related]  

  • 12. Immunotherapy of solid tumors: nonmyeloablative allogeneic stem cell transplantation.
    Childs RW
    MedGenMed; 2002 Jun; 4(3):13. PubMed ID: 12466756
    [No Abstract]   [Full Text] [Related]  

  • 13. Prenyldiphosphate synthase, subunit 1 (PDSS1) and OH-benzoate polyprenyltransferase (COQ2) mutations in ubiquinone deficiency and oxidative phosphorylation disorders.
    Mollet J; Giurgea I; Schlemmer D; Dallner G; Chretien D; Delahodde A; Bacq D; de Lonlay P; Munnich A; Rötig A
    J Clin Invest; 2007 Mar; 117(3):765-72. PubMed ID: 17332895
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Allogeneic stem cell transplantation corrects biochemical derangements in MNGIE.
    Hirano M; Martí R; Casali C; Tadesse S; Uldrick T; Fine B; Escolar DM; Valentino ML; Nishino I; Hesdorffer C; Schwartz J; Hawks RG; Martone DL; Cairo MS; DiMauro S; Stanzani M; Garvin JH; Savage DG
    Neurology; 2006 Oct; 67(8):1458-60. PubMed ID: 16971696
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Comparative diagnostic value of the analysis of the skeletal muscle and lymphocytes in mitochondrial diseases].
    Sukhorukov VS; Nartsissov RP; Petrichuk SV; Vasil'ev S; Nikolaeva EA; Kleĭmenova NV; Klembovskiĭ AI; Kazantseva LZ
    Arkh Patol; 2000; 62(2):19-21. PubMed ID: 10789008
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Coenzyme Q10 deficiency].
    Imataka G; Yamanouchi H
    Nihon Rinsho; 2002 Apr; 60 Suppl 4():462-5. PubMed ID: 12013914
    [No Abstract]   [Full Text] [Related]  

  • 17. Early coenzyme Q10 supplementation in primary coenzyme Q10 deficiency.
    Montini G; Malaventura C; Salviati L
    N Engl J Med; 2008 Jun; 358(26):2849-50. PubMed ID: 18579827
    [No Abstract]   [Full Text] [Related]  

  • 18. Diagnosis and treatment of mitochondrial myopathies.
    Pfeffer G; Chinnery PF
    Ann Med; 2013 Feb; 45(1):4-16. PubMed ID: 21867371
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tipping the scales in favour of mitochondrial gene therapy.
    Bigger B; Collombet JM; Coutelle C
    Gene Ther; 1999 Dec; 6(12):1909-10. PubMed ID: 10637441
    [No Abstract]   [Full Text] [Related]  

  • 20. Mutations in coenzyme Q10 biosynthetic genes.
    DiMauro S; Quinzii CM; Hirano M
    J Clin Invest; 2007 Mar; 117(3):587-9. PubMed ID: 17332886
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.